Health JackalAmgen shares rise on positive bone-drug studyBusinessWeekShares of Amgen Inc. jumped in premarket trading Wednesday after the company said its experimental osteoporosis drug denosumab met a key goal of preventing bone injuries in breast-cancer patients during a late-stage study. Its shares gained $7.22, ...Amgen Rises After Denosumab Bests Zometa in StudyBloombergAmgen Climbs Premarket On Bone Drug Trial >AMGNWall Street JournalAmgen shares jump after bone drug does well in testBizjournals.comHealth Jackal -MSN Money -Market Intelligence Centerall 72 news articles »